Mark Kowala

Mark Kowala

Company: Cardiobiopharma

Job title: President

Seminars:

Moderated Discussion – Assessing the Current & Future Landscapes for Preclinical Models 12:50 pm

Dissecting the advantages and disadvantages of current established preclinical models Ascertaining what should be done to improve translatability of animal models without extending drug development timeline Expanding our understanding of mechanisms driving safety for HFpEF targeted candidatesRead more

day: Day One

Understanding the Promise & Pitfalls of Pre-Clinical Models of HFpEF Understanding the Promise & Pitfalls of Pre-Clinical Models of HFpEF for a More Accurate Representation of the Human Disease 12:00 pm

Overview an up-to-date summary of HFpEF models and comparisons to patient phenotypes Review the clinical translation of old and new heart failure therapies Discuss exciting novel disease mechanisms derived from HFpEF models Analyze a realistic appraisal of HFpEF models purpose and value plus suggested future research directionsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.